Oramed Pharmaceuticals Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 3, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Aug '21 Aug 31, 2021	2020 - 2016
Market Capitalization	347	355	336	1,655	1,692	2,051	Upgrade
Market Cap Growth	-0.10%	5.88%	-79.72%	-2.19%	-17.53%	477.70%	Upgrade
Enterprise Value	-90	-167	-33	1,094	1,382	1,810	Upgrade
Last Close Price	8.89	8.51	8.20	38.83	40.80	63.30	Upgrade
PE Ratio	2.39	-	16.87	-	-	-	Upgrade
PS Ratio	52.34	-	69.54	174.08	200.54	236.73	Upgrade
PB Ratio	0.52	0.67	0.57	3.11	3.26	5.49	Upgrade
P/TBV Ratio	0.51	0.67	0.57	3.10	3.27	5.53	Upgrade
EV/Sales Ratio	-	-	-	115.15	163.83	208.87	Upgrade
EV/FCF Ratio	2.55	-	-	-	-	-	Upgrade
Debt / Equity Ratio	0.00	0.00	0.32	0.01	0.00	0.01	Upgrade
Asset Turnover	0.01	-	0.01	0.02	-	0.03	Upgrade
Quick Ratio	22.08	24.97	3.05	27.10	19.85	14.10	Upgrade
Current Ratio	22.25	25.19	3.06	27.34	20.08	14.27	Upgrade
Return on Equity (ROE)	24.48%	-12.39%	3.24%	-23.77%	-	-30.78%	Upgrade
Return on Assets (ROA)	-4.22%	-4.25%	-5.16%	-14.95%	-	-17.54%	Upgrade
Return on Capital (ROIC)	-4.53%	-4.44%	-5.38%	-15.90%	-	-20.18%	Upgrade
Return on Capital Employed (ROCE)	-6.10%	-8.50%	-9.40%	-26.00%	-21.70%	-20.00%	Upgrade
Earnings Yield	41.89%	-19.54%	5.93%	-7.77%	-6.44%	-3.48%	Upgrade
FCF Yield	-10.13%	-8.64%	-11.32%	-6.04%	-6.14%	-3.37%	Upgrade
Buyback Yield / Dilution	-3.29%	-0.65%	-4.02%	-5.08%	-30.36%	-16.71%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.